NCT04234113 2026-03-27Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsSotio Biotech Inc.Phase 1 Terminated115 enrolled 43 charts
NCT04284774 2025-12-04Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment TrialNational Cancer Institute (NCI)Phase 2 Active not recruiting5 enrolled 9 charts
NCT01709435 2023-12-22Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid TumorsNational Cancer Institute (NCI)Phase 1 Completed41 enrolled 20 charts
NCT02988817 2023-08-01Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid TumorsGenmabPhase 1/2 Completed306 enrolled 51 charts